A significant increase in carbapenem-resistance rates among Acinetobacter baumannii isolates collected in two Turkish medical centres was detected in the 2000-2006 period (20-60 %) by the SENTRY Antimicrobial Surveillance Program. Carbapenem-resistant strains from 2006 were evaluated for the presence of encoding genes and epidemic clonality. OXA-58-like and OXA-23-like carbapenemase-producing strains were detected in both medical institutions. Seventeen out of 18 strains from Ankara were positive for bla OXA-58 primers and belonged to the same clone, whilst 26 isolates (25 from Istanbul and one from Ankara) harboured bla OXA-23 -like genes and showed identical or similar PFGE patterns. Isolates producing OXA-23-like carbapenemases were more resistant than OXA-58-like carbapenemase producers to non-carbapenem antimicrobial agents. Carbapenem resistance in these institutions was observed to be largely driven by the dissemination of clones producing OXA-type carbapenemases.
INTRODUCTION
Acinetobacter baumannii represents an important cause of nosocomial infections, including septicaemia, ventilatorassociated pneumonia and urinary tract infections (Perez et al., 2007) . Furthermore, this pathogen may colonize hospitalized patients, especially those with severe underlying illnesses. Acinetobacter strains are usually resistant to multiple antimicrobial agents (Poirel & Nordmann, 2006) , and the carbapenems (imipenem or meropenem) represent an important option for the treatment of Acinetobacter infections caused by multidrug-resistant (MDR) isolates (Perez et al., 2007) .
Resistance to carbapenems in Acinetobacter species occurs due to the accumulation of various resistance mechanisms including b-lactamase production, which can be associated with the loss of outer-membrane porins and/or overexpression of efflux pumps or more rarely with penicillinbinding protein alterations (Poirel & Nordmann, 2006) . The production of metallo-b-lactamases (MbLs; Ambler class B) or carbapenem-hydrolysing oxacillinases (class D) may confer high-level resistance to carbapenems in Acinetobacter species . Although MbLs have been identified in a wide variety of Gram-negative species, this class of enzyme is not common in A. baumannii, in which the oxacillinases represent the most commonly acquired carbapenem-hydrolysing enzymes . Carbapenem resistance due to OXA-carbapenemases has been reported from diverse geographical origins including European countries, Latin America, Kuwait, Iraq and countries in the Western Pacific area (Marque et al., 2005; Poirel & Nordmann, 2006) .
Here, we evaluated the antimicrobial susceptibility of A. baumannii strains collected in Turkey through the SENTRY Antimicrobial Surveillance Program over a period of 7 years (2000) (2001) (2002) (2003) (2004) (2005) (2006) , and the mechanisms of resistance and epidemiology of carbapenem-resistant A. baumannii. ) and ceftazidime (MIC ¢32 mg ml 21 ) were screened for production of MbL using the MbL Etest (AB BIODISK). OXAtype carbapenemases were assessed using a multiplex PCR strategy as described previously (Woodford et al., 2006) . The association of bla OXA and the insertion sequences ISAba-1, -2 and -3 was also assessed.
METHODS
Molecular typing by PFGE. All carbapenem-resistant isolates from 2006 were also evaluated by PFGE. Additionally, these isolates were compared with susceptible A. baumannii strains from the same year. Bacterial cells grown overnight were embedded in agarose, lysed and deproteinated, and digested with SmaI. The restriction fragments were separated by electrophoresis on a CHEF DR II (Bio-Rad) under the following conditions: 1 % agarose, 0.56 TBE, 200 V and a switch interval ranging from 5 to 30 s over 23 h. Isolates showing three or fewer band differences were considered to be identical or similar and clonally related.
RESULTS AND DISCUSSION
A total of 321 A. baumannii isolates collected in medical centres located in Ankara and Istanbul (Turkey), mainly recovered from bloodstream (66.4 %) and respiratory tract (24.3 %) infections, were evaluated. The antimicrobial susceptibility profiles of the A. baumannii isolates are listed in Table 1 . The most active compounds against these isolates were polymyxin B (99.3 % susceptible) and tigecycline (99.0 % susceptible). Overall, the isolates showed approximately 52.0 % susceptibility to imipenem and meropenem; these antimicrobials were followed in coverage by tobramycin (43.9 % susceptible). However, the stratification of the imipenem susceptibility rates in the 7-year period demonstrated a gradual and significant decrease in these rates, from 80. (Fig. 1) different PFGE pattern from the OXA-58-like-producing isolates from Ankara. The 26 OXA-23-like-producing isolates (25 from Istanbul and one from Ankara) were found to be genetically related ( Table 2 ), suggesting that this clone disseminated in these two Turkish cities. Oxacillinase-producing strains were distinct from susceptible A. baumannii isolates from the same medical sites. Susceptible isolates showed a great genetic diversity when compared with the oxacillinase-producing isolates, showing 11 different PFGE patterns among 18 isolates selected for evaluation. All 44 isolates were confirmed as A. baumannii based on a positive PCR result using primers for bla OXA-51 , a cluster of constitutive oxacillinase genes found in the chromosome of this species.
The insertion sequences ISAba-1, -2 and -3 have been associated with carbapenem-hydrolysing oxacillinases (Corvec et al., 2007; Poirel & Nordmann, 2006; Segal et al., 2007) . When located upstream of the bla OXA genes, these genetic elements can supply a transcriptional promoter that upregulates the expression of these blactamases. The ISAba-3 element was detected upstream of the bla OXA-58 -like gene in all isolates; however, none of the ISAba elements described were found to be related to bla OXA-23 -like genes in the isolates evaluated in this study.
In general, the carbapenem-resistant A. baumannii isolates from 2006 showed high rates of co-resistance to all other antimicrobials tested, except polymyxin B (100.0 % susceptible) and tigecycline (100.0 % inhibited at ¡2 mg ml
21
). Of note, the isolates from Istanbul showed higher rates of resistance to other antimicrobial classes (Table 1) . Among 36 A. baumannii isolates from Istanbul, 26 produced OXA enzymes corresponding to 72.2 % of the isolates, whilst in Ankara, the proportion of OXAproducing strains was lower (46.2 %). The high occurrence of OXA-producing strains may reflect increasing rates of resistance to non-carbapenem antimicrobial agents, as well as to the carbapenems.
Molecular epidemiology studies in recent years have documented several outbreaks of multidrug-resistant clones of A. baumannii in Turkish hospitals (Alp et al., 2006; Vahaboglu et al., 2006) . In addition, various carbapenemases have been described in Turkey, including oxacillinase-producing A. baumannii. However, isolates producing these enzymes have been observed in small numbers and with restricted geographical diversity (Marque et al., 2005) . In this study, we demonstrated that the dramatic decrease in carbapenem susceptibility rates among A. baumannii in 2006 was attributed to the clonal dissemination of OXA-producing strains and that carbapenem resistance was found to be driven largely by OXA-58 in Ankara and OXA-23 in Istanbul, both of which have become more prevalent in Europe in recent years Poirel & Nordmann, 2006) . The dissemination of A. baumannii clones carrying oxacillinase genes that were largely recovered from intensive care unit patients (51.4 %) highlights the importance of hospital infection control measures and the need for a more extensive local molecular epidemiology surveillance programme throughout Europe. (26) OXA-23 (25) B (7), B1 (5), B2 (13) OXA-58 (1) C (1) *The capital letter defines the PFGE pattern, with subtypes identified by a number.
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